Literature DB >> 30318155

Arginine methylation of FOXP3 is crucial for the suppressive function of regulatory T cells.

Yuki Kagoya1, Hiroshi Saijo1, Yukiko Matsunaga1, Tingxi Guo2, Kayoko Saso1, Mark Anczurowski2, Chung-Hsi Wang2, Kenji Sugata1, Kenji Murata1, Marcus O Butler3, Cheryl H Arrowsmith4, Naoto Hirano5.   

Abstract

Forkhead box transcription factor 3 (FOXP3) plays a pivotal role in the suppressive function of regulatory T cells. In addition to mRNA levels, FOXP3 activity can also be controlled by posttranslational mechanisms, which have not been studied in a comprehensive manner. Through extensive screening using selective inhibitors, we demonstrate that the inhibition of type I protein arginine methytransferases (PRMTs) attenuates the suppressive functions of regulatory T cells. FOXP3 undergoes methylation on arginine residues at positions 48 and 51 by interacting with protein arginine methyltransferase 1 (PRMT1). The inhibition of arginine methylation confers gene expression profiles representing type I helper T cells to FOXP3+ T cells, which results in attenuated suppressive activity. A methylation-defective mutant of FOXP3 displays less potent activity to suppress xenogeneic graft-versus-host disease in vivo. These results elucidate an important role of arginine methylation to enhance FOXP3 functions and are potentially applicable to modulate regulatory T cell functions.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arginine methylation; FOXP3; Graft-versus-host disease; PRMT1; Posttranslational modification; Regulatory T cells

Mesh:

Substances:

Year:  2018        PMID: 30318155     DOI: 10.1016/j.jaut.2018.09.011

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  11 in total

Review 1.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

Review 2.  The emerging role of transcription factor FOXP3 in thyroid cancer.

Authors:  Zhongqin Gong; Hao Jia; Lingbin Xue; Dongcai Li; Xianhai Zeng; Minghui Wei; Zhimin Liu; Michael C F Tong; George G Chen
Journal:  Rev Endocr Metab Disord       Date:  2021-08-31       Impact factor: 6.514

3.  Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.

Authors:  Andrew Fedoriw; Leilei Shi; Shane O'Brien; Kimberly N Smitheman; Yunfei Wang; Jiakai Hou; Christian Sherk; Satyajit Rajapurkar; Jenny Laraio; Leila J Williams; Chunyu Xu; Guangchun Han; Qin Feng; Mark T Bedford; Linghua Wang; Olena Barbash; Ryan G Kruger; Patrick Hwu; Helai P Mohammad; Weiyi Peng
Journal:  Cancer Immunol Res       Date:  2022-04-01       Impact factor: 12.020

4.  Bone Mesenchymal Stem Cell-Derived Exosome-Enclosed miR-181a Induces CD4+CD25+FOXP3+ Regulatory T Cells via SIRT1/Acetylation-Mediated FOXP3 Stabilization.

Authors:  Renyong Wang; Ruixue Li; Tiehan Li; Lei Zhu; Zongze Qi; Xiaokui Yang; Huan Wang; Baoquan Cao; Hong Zhu
Journal:  J Oncol       Date:  2022-05-26       Impact factor: 4.501

Review 5.  Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.

Authors:  Weijing Dai; Jianguo Zhang; Siqi Li; Fajian He; Qiao Liu; Jun Gong; Zetian Yang; Yan Gong; Fang Tang; Zhihao Wang; Conghua Xie
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786

Review 6.  Foxp3 Post-translational Modifications and Treg Suppressive Activity.

Authors:  Guoping Deng; Xiaomin Song; Shigeyoshi Fujimoto; Ciriaco A Piccirillo; Yasuhiro Nagai; Mark I Greene
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 7.  Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.

Authors:  Yi Dong; Cuiping Yang; Fan Pan
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

Review 8.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

Review 9.  PRMT5 function and targeting in cancer.

Authors:  Hyungsoo Kim; Ze'ev A Ronai
Journal:  Cell Stress       Date:  2020-07-13

Review 10.  How Protein Methylation Regulates Steroid Receptor Function.

Authors:  Lucie Malbeteau; Ha Thuy Pham; Louisane Eve; Michael R Stallcup; Coralie Poulard; Muriel Le Romancer
Journal:  Endocr Rev       Date:  2022-01-12       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.